Selective serotonin reuptake inhibitors provide significant lower re-hospitalization rates in patients recovering from acute coronary syndromes: Evidence from a meta-analysis

Journal of Psychopharmacology

Volumn 24, Issue 12, 2010, Pages 1785-1792

  Mazza, Marianna ^a   Lotrionte, Marzia ^a   Biondi Zoccai, Giuseppe ^b   Abbate, Antonio ^c   Sheiban, Imad ^b   Romagnoli, Enrico ^d  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

acute coronary syndrome; coronary heart disease (CHD); depression; meta analysis; selective serotonin reuptake inhibitors (SSRIs)

Indexed keywords

CITALOPRAM; FLUOXETINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ACUTE CORONARY SYNDROME; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

ACUTE CORONARY SYNDROME; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER; HOSPITALIZATION; HUMANS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 78650088616     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881109348176     Document Type: Article

References (35)

1. Agostoni P., Biondi-Zoccai GGL, De Benedictis ML, et al. (2004) Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures. J Am Colle Cardiol 44: 349-356.
2. Berkman LF, Blumenthal J., Burg M., et al. (2003) Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancinh Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 289: 3106-3116.
3. Biondi-Zoccai GGL, Abbate A., Agostoni P. (2003) Parallel hierarchy of clinical research in cardiovascular medicine. Ital Heart J 4: 819-820.
4. Biondi-Zoccai GG, Agostoni P., Abbate A., Testa L., Burzotta F. (2005) A simple hint to improve Robinson and Dickersin's highly sensitive PubMed search strategy for controlled clinical trials. Int J Epidemiol 34: 224-225.
5. Blumenthal JA, Sherwood A., Rogers SD, et al. (2007) Understanding prognostic benefits of exercise and antidepressant therapy for persons with depression and heart disease: the UPBEAT study-rationale, design, and methodological issues. Clin Trials 4: 548-559.
6. Burg MM, Lesperance F., Rieckmann N., Clemow L., Skotzko C., Davidson KW (2008) Treating persistent depressive symptoms in post-ACS patients. The project COPES phase-I randomized controlled trial. Contemp Clin Trials 70 (1). 7-12.
7. Carney RM, Blumenthal JA, Freedland KE, et al. for the ENRICHD Investigators (2004) Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) Study. Psychosom Med 66: 466-474.
8. Carney RM, Freedland KE (2007) Depression and coronary heart disease: more pieces in the puzzle. Am J Psychiat 164: 1307-1308.
9. de Jonge P., Honig A., van Melle JP, et al. for the MIND-IT Investigators (2007) Non-response to treatment for depression following myocardial infarction: association with subsequent cardiac events. Am J Psychiat 164: 1371-1378.
10. Freasure-Smith N., Lesperance F., Talajic M. (1993) Depression following myocardial infarction: impact on 6-month survival. JAMA 270: 1819-1825.
11. Freasure-Smith N., Lesperance F., Talajic M. (1995) Depression and 18-month prognosis after myocardial infarction. Circulation 91: 999-1005.
12. Glassman AH, Bigger JT, Gaffney M., Shapiro PA, Swenson JR (2006) Onset of major depression associated with acute coronary syndromes. Relationship of onset, major depressive disorder history, and episode severity to sertraline benefit. Arch Gen Psychiat 63: 283-288.
13. Glassman AH, Bigger JT, Gaffney M., van Zyl L. (2007) Heart rate variability in acute coronary syndrome patients with major depression. Influence of sertraline and mood improvement. Arch Gen Psychiat 64: 1025-1031.
14. Glassman AH, O'Connor CM, Califf RM, et al. for the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group (2002) Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288: 701-709.
15. Hamilton MA (1960) A rating scale for depression. J Neurol, Neurosurg and Psychiat 23: 56-62.
16. Higgins JPT, Green S (eds) (2008) Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1 (updated September 2008). The Cochrane Collaboration. Available at: www.cochrane-handbook.org.
17. Honig A., Kuyper AMG, Schene AH, et al. on behalf of the MIND-IT Investigators (2007) Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazepine. Psychoso Med 69: 606-613.
18. Lesperance F., Frasure-Smith N., Koszycki D., et al. for the CREATE Investigators (2007) Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary heart disease. The Canadian Cardiac Randomized Evaluation of Antidepressant and psychotherapy Efficacy (CREATE) trial. JAMA 297: 367-379.
19. McFarlane A., Kamath MV, Fallen EL, Malcom V., Cherian F., Norman G. (2001) Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction. Am Heart J 142: 617-623.
20. Mohapatra PK, Kar N., Kar GC, Behera M. (2005) Effectiveness of sertraline in treatment of depression in a consecutive sample of patients with acute myocardial infarction: six month prospective study on outcome. Clin Practice and Epidemiol in Mental Health 1: 26-30.
21. O'Connor CM, Glassman AH, Harrison DJ (2005) Pharmacoeconomic analysis of sertraline treatment of depression in patients with unstable angina or a recent myocardial infarction. J Clin Psychiat 66: 346-352.
22. Post RM (1992) Transduction of psychosocial stress into the neuro-biology of recurrent affective disorder. Am J Psychiat 149: 999-1010.
23. Regan KL (2008) Depression treatment with selective serotonin reuptake inhibitors for the postacute coronary syndrome population: a literature review. J Cardiovasc Nursing 23: 489-496.
24. Roose SP, Laghrissi- Thode F., Kennedy JS, et al. (1998) Comparison of paroxetine and nortriptyline in depressed patients with ischemich heart disease. JAMA 279: 287-291.
25. Schweikert B., Hunger M., Meisinger C., et al. (2009) Quality of life several years after myocardial infarction: comparing the MONICA/KORA registry to the general population. Eur Heart J 30: 436-443.
26. Serebruany VL, Glassman AH, Malinin AI, et al. for the SADHART Study Group (2003) Platelet/Endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events. The sertraline antidepressant heart attack randomized trial (SADHART) platelet sub-study. Circulation 108: 939944.
27. Strik Jjmh, Honig A., Lousberg R., et al. (2000) Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosom Med 62: 783-789.
28. Swenson JR, O'Connor CM, Barton D., et al. for the SADHART Group (2003) Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome. Am J Cardiol 92: 1271-1276.
29. Tata LJ, West J., Smith C., et al. (2005) General population based study of the impact of triciclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart 91: 465-471.
30. Taylor CB, Youngblood ME, Catellier D., et al. for the ENRICHED Investigators (2005) Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiat 62: 792-798.
31. Thombs BD, de Jonge P., Coyne JC, et al. (2008) Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA 300: 2161-2671.
32. van den Brink RHS, van Melle JP, Honig A., et al. on behalf of the MIND-IT Investigators (2002) Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: rationale and outline of the Myocardial Infarction and Depression-Intervention Trial (MIND-IT). Am Heart J 144: 219-225.
33. van Melle JP, De Jonge P., Honig AA, et al. on behalf of the MIND-IT Investigators (2007) Effects of antidepressant treatment following myocardial infarction. Brit J Psychiat 190: 460-466.
34. van Zyl LT, Lesperance F., Frasure-Smith N., et al. (2009) Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study. J Thromb Thrombolys 27: 48-56.
35. Zimmerman M., Coryell W., Corenthal C., Wilson S. (1986) A self-report scale to diagnose major depressive disorder. Arch Gen Psychiat 43: 1076-1081.